Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies-Reference-Cited by-同舟云学术

Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies

Published:2020-01-17 Issue:3 Volume:40 Page:197-209
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Nagai Kota,Matsubayashi Keisuke,Ide Kazuki,Seto Kahori,Kawasaki Yohei,Kawakami Koji^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-020-00887-6.pdf

Reference52 articles.

1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.

2. Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68:1–25.

3. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–77.

4. Emery P. Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment. Rheumatology (Oxford). 2012;51(Suppl 5):v22–30.

5. Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov. 2016;15:305–6.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials;ACR Open Rheumatology;2022-06-30

2. Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis;Annals of the Rheumatic Diseases;2022-06-20

3. Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial;The Lancet Rheumatology;2022-06

4. The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysis;Zeitschrift für Rheumatologie;2021-11-10

5. Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis;Rheumatology;2021-10-19